All Articles

This article includes immunotherapies approved through May 2017. Read More ›

According to the Cancer Research Institute, only 3% to 6% of eligible patients with cancer participate in clinical trials in the United States. Read the reasons why clinical trials are a great option to consider. Read More ›

Catherine Poole breaks down the emerging immunotherapy options for Melanoma, not to be confused with the common skin cancers (basal-cell carcinoma and squamous-cell carcinoma) largely caused by exposure to UV rays. Read More ›

“We are continuing to learn about the ways the immune system interacts with difference types of cancer, including multiple myeloma,” said Dr. Pazdur of the FDA. Read More ›

Immunotherapy is all the rage today, but like any other treatment, it comes with side effects. Learn how to recognize and manage some of the common side effects. Read More ›

Immunotherapies expose cancer cells to the immune system so it can attack them. Read about why these drugs work so well in some patients but in others the immune system doesn’t respond to these very promising drugs. Read More ›

Check out some of the most exciting immunotherapies that are giving hope to people fighting this disease, which is responsible for 1 in every 4 cancer-related deaths in the United States. Read More ›

Take a look at the 5 new promising immunotherapies approved by the FDA for bladder cancer after decades of no new treatment options for this type of cancer. Read More ›

George Ford, who was 7 years old during WWII, offers his personal perspective brimming with insight as he recounts his journey with esophageal cancer. Read More ›

Read about Greta Stifel’s battle with a NET diagnosis and her mission to spread awareness of NETs and empower others dealing with this rare, often misdiagnosed cancer type. Read More ›